Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Fund Letter | Howard GleicherAristotle Value Equity Fund | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Aristotle Value Equity Fund - EW Headquartered in Irvine, California, Edwards Lifesciences (Edwards) is a global leader in structural heart disease therapies, developing and commercializing medical devices used to treat advanced cardiovascular conditions. The company is... | NEUTRAL | View Pitch → | |
| Sep 2, 2026 | Fund Letter | Ron BaronBaron Partners Fund | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Baron Asset Fund - EW We initiated a position in Edwards Lifesciences Corporation, a leading manufacturer of heart valve replacement and repair products. Edwards has dominant... | NEUTRAL | View Pitch → | |
| Aug 21, 2026 | Fund Letter | David F. RidlandCastlebay Investments | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Long EW (Edwards Lifesciences Corp.) Edwards Lifesciences is a genuinely high-quality business. Its clinical moat... | BULL | View Pitch → | |
| Aug 21, 2026 | Fund Letter | Rudi van NiekerkDesert Lion Capital | -- | Long LEW.JO (Lewis) Furniture retailer Lewis demonstrated strong profitability with operating margin expansion and 16.8% headline earnings growth, supported by a healthy and stable credit book. Despite facing a... | BULL | View Pitch → | |
| Aug 20, 2026 | Substack | triplesinvestingSubstack (triplesinvesting) | Independent Power Producers & Energy TradersIndependent Power and Renewable Electricity Producers | Santa Barbara GoldEnergy World Corporation – EWC.AX Energy World Corporation is on the verge of a turnaround, having sold gas turbines for $350 million, which is double its market cap. The company will... | BULL | View Pitch → | |
| Aug 4, 2026 | Substack | triplesinvestingSubstack (triplesinvesting) | Independent Power Producers & Energy TradersIndependent Power and Renewable Electricity Producers | Santa Barbara GoldEnergy World Corporation Ltd – EWC.AX Energy World Corporation is undergoing a significant transformation, selling gas turbines for $350M, which is double its market cap, and eliminating its debt. The sa... | BULL | View Pitch → | |
| May 10, 2026 | Substack | Everyone Hates Poetry | GrabAGun.com $PEW• NYSE | Aerospace & DefenseAerospace & Defense | GrabAGun Digital (NYSE: PEW) The company has significant asymmetric upside due to its newly launched 'PEW Logistics' platform. This B2B solution... | BEAR | View Pitch → |
| Jan 16, 2026 | Fund Letter | David A. Rolfe, Michael X. Quigley, Christopher T. JersanWedgewood Partners | Health Care Equipment & SuppliesHealth Care Equipment & Supplies | Wedgewood Partners 2025 Q4 (EW) Edwards Lifesciences also contributed to performance during the quarter. The Company presented... | BULL | View Pitch → | |
| Nov 28, 2025 | Fund Letter | Brandon BeyloMacro ops | New Pacific Metals Corp. $NEWP• NASDAQ | Metals & MiningMetals & Mining | Macro Ops 2025 Q3 (NEWP) New Pacific Metals operates three Bolivian projects—Silver Sand, Carangas, and Silverstrike—that could collectively become the world's second-largest silver production hub after Pan American Silver. With 40%+ IRRs... | BULL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.